teleo-codex/entities/health/evernorth-encirclerx.md
Teleo Agents 6c85418b25 vida: extract claims from 2026-04-28-glp1-managed-access-operating-systems-payer-infrastructure
- Source: inbox/queue/2026-04-28-glp1-managed-access-operating-systems-payer-infrastructure.md
- Domain: health
- Claims: 2, Entities: 2
- Enrichments: 4
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
2026-04-28 04:18:51 +00:00

1.1 KiB

Evernorth EncircleRx

Type: Managed-access program (PBM infrastructure) Parent: Evernorth (Cigna) Domain: GLP-1 utilization management Status: Active

Overview

Evernorth EncircleRx is a managed-access operating system for GLP-1 receptor agonists, managing utilization and cost across 9 million enrolled lives as of 2026.

Program Structure

Cost containment mechanisms:

  • 15% cost cap guarantee
  • 3:1 savings guarantee (alternative structure)
  • $200 copay cap on Wegovy and Zepbound (added 2025)

Operational scale:

  • 9 million enrolled lives
  • ~$200 million saved since 2024

Strategic Context

EncircleRx represents Evernorth's response to GLP-1 fiscal pressure (10x PMPM increase 2023-2024) by building multi-layer infrastructure beyond traditional formulary management. The program competes with:

  • Optum Rx Weight Engage (UHC)
  • Manufacturer direct-to-employer channels (Lilly Employer Connect, Novo Nordisk DTE)

Timeline

  • 2024 — EncircleRx launched
  • 2025 — Added $200 copay cap on Wegovy and Zepbound
  • 2026 — Managing 9M lives, ~$200M cumulative savings reported